{"title": "Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results", "author": null, "url": "https://www.fiercebiotech.com/biotech/aeras-crucell-and-south-african-tuberculosis-vaccine-initiative-announce-encouraging", "hostname": "fiercebiotech.com", "description": "Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine ATLANTA, April 9, 2008 -- Dutch biotechnology company Crucell N.V., | Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine ATLANTA, April 9, 2008 -- Dutch biotechnology company Crucell N.V.,", "sitename": "FierceBiotech", "date": "2008-04-10", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Subscribe Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}